Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.
about
Immunization of children with secondary immunodeficiencyPremature B-cell senescence as a consequence of chronic immune activation.Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTHIV reservoirs and immune surveillance evasion cause the failure of structured treatment interruptions: a computational studyEarly ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal DatasetParadoxical aging in HIV: immune senescence of B Cells is most prominent in young age.HS1,2 Ig enhancer alleles association to AIDS progression in a pediatric cohort infected with a monophyletic HIV-strainHuman herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment.Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccinationMeasles outbreak in Africa--is there a link to the HIV-1 epidemic?Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theFrequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.Guidance on vaccination of HIV-infected children in Europe.B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy.Immunologic basis for revaccination of HIV-infected children receiving HAART.Response to Pneumococcal Polysaccharide Vaccination in HIV-Positive Individuals on Long Term Highly Active Antiretroviral Therapy.Delayed reconstitution of B cell immunity to pneumococcus in HIV-infected Malawian children on antiretroviral therapy.Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets.Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naïve for HAART is related to reduced immune surveillance.Impaired Phenotype and Function of T Follicular Helper Cells in HIV-1-Infected Children Receiving ARTControl of Viremia Enables Acquisition of Resting Memory B Cells with Age and Normalization of Activated B Cell Phenotypes in HIV-Infected ChildrenSeroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.[Persistence of hepatitis A virus antibodies after primary immunization and response to revaccination in children and adolescents with perinatal HIV exposure]Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartmentInflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative AdultsImmunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without InfectionAltered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection.Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.Paediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses.Alterations of the B-cell response by HIV-1 replicationHIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation.Diphtheria Antibodies and T lymphocyte Counts in Patients Infected With HIV-1Immediate access to antiretroviral therapy is important in children living with HIV.Antiretroviral therapy restores age-dependent loss of resting memory B cells in young HIV-infected Zambian children.Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals.Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.Human immunodeficiency virus antibodies and the vaccine problem.
P2860
Q26801474-FB88AB14-2E00-409F-BE2D-22E9D0268DC8Q27693281-165FC17D-CCCC-454B-BFC4-4327A78D776CQ28476094-EFBDC557-14C9-4354-ADEC-B5724CD24FD8Q28482710-A2A8513F-69C4-4EAA-98E9-ECCD7D5D3616Q29999998-A16DA3BC-0D19-4AE7-9B50-E2D738602383Q33657511-854EBD0F-B939-498B-AA9B-F31AE69B5492Q33746124-B516FF4A-58EF-49AE-92FC-2CE0F60F8820Q33760703-A442851D-BEBE-4AD6-898D-51F0B80D9803Q33820427-A188CD1F-5771-4262-B778-F10EAF8F23CBQ33828579-81931DC9-7E2F-4DDE-B7CD-7ABF6180C590Q34196888-1CE4593D-4321-4D40-95E2-AB9C5F0CD648Q34212799-BDFA5CB2-2280-4066-AEC9-3A4891B1F30BQ34233791-1B95D8BE-DA5A-4C0D-A6B1-E6237B2FB4F5Q34251138-97919C53-06F4-41D7-BC04-6E195E2D27C1Q34541705-B9FB3C42-2A80-486F-9139-0202E86779C8Q34575987-4835F23F-255F-407C-9F72-69C29FDE7C78Q35511280-177A3C1D-6BE5-4064-B489-6232BD8EAF3AQ35635685-5F4FBD84-1A78-4E89-83E6-21DA8A8CE6B9Q35810521-C32A11D0-1E00-4471-A8A3-D6F74AEFDEB0Q35830092-22202370-6950-40B7-B6A3-C2B79F201531Q35857848-FB1068F3-BD94-4AA4-ABE2-865D41F3C1AAQ35861977-D5EBF0BA-7935-4518-9C2E-5BB4918A6FD5Q35887330-A1CBE29A-870D-4657-BFCC-A7BDDF037FC2Q35892948-96B3A774-8BD7-4D36-91A8-F5413E8A9C2CQ35895763-53A08A7A-76F3-4A48-9B47-0CDF2ADB75E4Q35940864-39799B91-1F68-432B-99AE-F7B49CD973E8Q35999709-683F6DF1-2E73-4B84-A556-70A1F44506B7Q36087130-EE913922-08D0-4A60-8064-2C414EAC8523Q36369132-B2098BB9-E493-4684-89E5-21EFBE7A85E3Q36379247-CB252C8D-7133-478A-A211-40FDCCCF1155Q36487031-7DC269B0-5837-4550-8045-E4E08E654BBAQ36802244-2FD8D816-DCE0-4E29-B009-4855F658C37BQ36933809-822E529E-85A3-47C0-8850-7FA60141B88BQ37159954-1116DF87-14EB-4FC6-80B1-BC20F86D710FQ37704932-49CB5344-EFDE-4243-ABEC-1564E6CA6239Q37722619-0C2F6692-393F-4C29-97BC-1992431A9C8AQ38036063-6E44943D-962D-4ED0-91CE-14566BCA1F9FQ38114912-6D30BBBA-C1BC-446B-BDAB-D7D29703F95EQ38177767-0FD045BB-5B08-4CBF-B0AF-CE53246A0E09Q38192126-5FBEFFA0-3E8F-4252-BC6C-B4BD54250053
P2860
Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Timing of HAART defines the in ...... vertically-infected children.
@en
Timing of HAART defines the in ...... vertically-infected children.
@nl
type
label
Timing of HAART defines the in ...... vertically-infected children.
@en
Timing of HAART defines the in ...... vertically-infected children.
@nl
prefLabel
Timing of HAART defines the in ...... vertically-infected children.
@en
Timing of HAART defines the in ...... vertically-infected children.
@nl
P2093
P2860
P50
P356
P1476
Timing of HAART defines the in ...... vertically-infected children.
@en
P2093
Claudia Capponi
Elio Freda
Rigmor Thorstensson
Simone Pensieroso
P2860
P304
P356
10.1073/PNAS.0901702106
P407
P577
2009-04-27T00:00:00Z